MedPage Today -- Citing a lack of evidence that reducing serum levels of highly-sensitive C-reactive protein (CRP) can reduce the risk of heart attacks and stroke, the U.S. Preventive Services Task Force (USPSTF) said it will not add CRP to its recommendations for assessing the risk of coronary heart disease.
